SLDB: Rasio P/E diaturake wutah solidbio.com
Solid Biosciences Inc. (SLDB) develops unique treatments for muscle pathologies, securing long-term revenue through patent protection. The PEG ratio confirms the asset's market value, with the indicator currently at 0.00. Pipeline growth is supported by a strong team of geneticists, while strategic alliances with clinics and M&A deals enhance the company's scientific potential.
Rincian metrik lan analitis perusahaan Solid Biosciences Inc. (SLDB)
- rega lan prakiraan konsensus rega:
- informasi kapitalisasi pasar:
- rincian valuasi buku bisnis:
- rincian struktur utang lan likuiditas bisnis:
Koefisien Total Utang marang Modal Solid Biosciences Inc.|SLDB - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang modal solidbio.com|SLDB - Utang perusahaan|Utang-utang marang aset resik Solid Bio|SLDB - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Solid Biosciences|Koefisien jangkoan perantara solidbio.com
- informasi bathi lan kelipatan valuasi:
SLDB - Bathi resik|Bathi resik sing dikarepake Solid Biosciences Inc.|SLDB - Rasio rega marang bathi|Rasio rega marang bathi mangsa ngarep Solid Corp|SLDB - Pangali PEG|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Solid Bio|SLDB - Bathi operasional EBITDA|Bathi resik saben siji saham sajrone rolas wulan pungkasan Solid Biosciences|SLDB - Bathi saben saham sajrone rolas wulan pungkasan|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan solidbio.com|SLDB - Wutah bathi resik saben saham ing taun iki|Dinamika bathi saben saham sing diarepake ing taun ngarep Solid Biosciences Inc.
Analisis fundamental perusahaan:SLDB, Solid Biosciences Inc
For Solid Biosciences Inc. (SLDB), whose valuation is based on confidence in the safety of gene therapy, the ratio of company value to growth rates on GURU.Markets serves as an indicator of fundamental potential. This metric compares the current P/E with earnings dynamics: a value below one signals that the asset is undervalued, allowing investors to objectively assess the market value of promising developments relative to their scaling rates.
Perusahaan pesaing
Kapitalisasi marang bathi resik kanthi nimbang wutah Tempus AI, Inc|Pangali PEG QGEN (Qiagen Group)|IONS: Rasio P/E diaturake wutah|RGEN: Pangali rega marang bathi tumrap wutah|Koefisien bali modal nimbang wutah RNA (aviditybiosciences.com)|CRSP: Pangali PEG|WGS (GeneDx Holdings) - Rasio rega marang bathi tumrap wutah|RARE (Ultragenyx Pharma) - Pangali PEG|Beam Tx (BEAM) - Kapitalisasi marang bathi resik kanthi nimbang wutah|Rasio rega marang bathi tumrap wutah Sarepta Therapeutics, Inc. (SRPT)|TWST - Rega marang bathi kanthi panyesuaian wutah|Rasio rega marang bathi tumrap wutah 10x Genomics TXG|Kapitalisasi marang bathi resik kanthi nimbang wutah Intellia Therapeutics Inc (NTLA)|Stoke - Pangali PEG|BioLife (BLFS) - Pangali rega marang bathi tumrap wutah|WVE: Pangali PEG|MAZE - Kapitalisasi marang bathi resik kanthi nimbang wutah|SION (Sionna Therapeutics) - Pangali PEG|Rega marang bathi kanthi panyesuaian wutah Prime Medicine Inc PRME|Rasio rega marang bathi tumrap wutah Taysha (TSHA)|uniQure Pharma - Rasio P/E diaturake wutah|Pangali PEG MGTX (MeiraGTx Holdings plc)|RGNX - Pangali rega marang bathi tumrap wutah|Ocugen - Pangali PEG|Rega marang bathi kanthi panyesuaian wutah Pacific Biosciences of California, Inc.|Benitec (BNTC) - Rasio rega marang bathi tumrap wutah|DSGN - Kapitalisasi marang bathi resik kanthi nimbang wutah|Pangali rega marang bathi tumrap wutah RCKT|FDMT: Koefisien bali modal nimbang wutah|Pangali PEG LXEO|Kapitalisasi marang bathi resik kanthi nimbang wutah korrobio.com|Rasio rega marang bathi tumrap wutah Editas EDIT|SLN: Rasio P/E diaturake wutah|ProQR Therapeutics NV - Pangali PEG|Codexis, Inc. (CDXS) - Pangali rega marang bathi tumrap wutah|SGMO (Sangamo Therapeutics, Inc.) - Pangali rega marang bathi tumrap wutah|NAUT - Kapitalisasi marang bathi resik kanthi nimbang wutah|Rasio rega marang bathi tumrap wutah Metagenomi, Inc|Precision BioSciences Inc. (DTIL) - Kapitalisasi marang bathi resik kanthi nimbang wutah|Rasio rega marang bathi tumrap wutah Generation Bio Co. (GBIO)|Rasio rega marang bathi tumrap wutah BOLD (boundlessbio.com)|Pangali PEG XCUR (Exicure)|IMNN: Rasio P/E diaturake wutah|RXi Pharmaceuticals - Pangali PEG|MBIO: Rasio rega marang bathi tumrap wutah|RNAZ: Pangali PEG|Rasio P/E diaturake wutah BNGO|Rasio rega marang bathi tumrap wutah Applied DNA Sciences, Inc.|Rasio P/E diaturake wutah BLUE (bluebird bio Inc.)|Pangali PEG IPA|Pangali PEG Omega Therapeutics Corp (OMGA)|Rasio rega marang bathi tumrap wutah Singular Genomics Systems OMIC|Kapitalisasi marang bathi resik kanthi nimbang wutah regulusrx.com (RGLS)|SYRS - Rasio rega marang bathi tumrap wutah|Rega marang bathi kanthi panyesuaian wutah Telesis Bio Inc.|TRACON (TCON) - Rasio rega marang bathi tumrap wutah|UBX (Unity Biotechnology, Inc) - Rasio rega marang bathi tumrap wutah
